ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Mibe Pharma UK Ltd

Mibe Pharma UK Ltd is an active company incorporated on 27 October 2017 with the registered office located in London, City of London. Mibe Pharma UK Ltd was registered 8 years ago.
Status
Active
Active since incorporation
Company No
11034700
Private limited company
Age
8 years
Incorporated 27 October 2017
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 18 August 2025 (2 months ago)
Next confirmation dated 18 August 2026
Due by 1 September 2026 (10 months remaining)
Last change occurred 1 month ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
4 Coleman Street
6th Floor
London
EC2R 5AR
United Kingdom
Same address since incorporation
Telephone
01271 334609
Email
Unreported
Website
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • German • Lives in Germany • Born in Oct 1965
Wilhelm Beier
PSC • German • Lives in Germany • Born in Apr 1956
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Rose Arches Company Limited
VP Secretarial Limited is a mutual person.
Active
Percival Aviation Limited
VP Secretarial Limited is a mutual person.
Active
Resco Products (UK) Limited
VP Secretarial Limited is a mutual person.
Active
Tods Defence Limited
VP Secretarial Limited is a mutual person.
Active
Asiaspan Limited
VP Secretarial Limited is a mutual person.
Active
Violia Media Services Limited
VP Secretarial Limited is a mutual person.
Active
Transatlantic Publishers Group Limited
VP Secretarial Limited is a mutual person.
Active
Sterling Investment Holdings Limited
VP Secretarial Limited is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2018–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£17.84K
Decreased by £19.17K (-52%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£199.69K
Decreased by £233.38K (-54%)
Total Liabilities
-£2.83M
Decreased by £128.91K (-4%)
Net Assets
-£2.63M
Decreased by £104.47K (+4%)
Debt Ratio (%)
1418%
Increased by 734.26% (+107%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 8 Sep 2025
Confirmation Submitted
1 Month Ago on 8 Sep 2025
Full Accounts Submitted
1 Year 1 Month Ago on 25 Sep 2024
Confirmation Submitted
1 Year 2 Months Ago on 19 Aug 2024
Confirmation Submitted
2 Years 2 Months Ago on 18 Aug 2023
Full Accounts Submitted
2 Years 6 Months Ago on 27 Apr 2023
Mark Charles Inker Resigned
2 Years 11 Months Ago on 23 Nov 2022
Confirmation Submitted
3 Years Ago on 24 Aug 2022
Full Accounts Submitted
3 Years Ago on 10 Aug 2022
Confirmation Submitted
4 Years Ago on 10 Sep 2021
Get Credit Report
Discover Mibe Pharma UK Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 18 August 2025 with updates
Submitted on 8 Sep 2025
Total exemption full accounts made up to 31 December 2024
Submitted on 8 Sep 2025
Total exemption full accounts made up to 31 December 2023
Submitted on 25 Sep 2024
Confirmation statement made on 18 August 2024 with updates
Submitted on 19 Aug 2024
Confirmation statement made on 18 August 2023 with updates
Submitted on 18 Aug 2023
Total exemption full accounts made up to 31 December 2022
Submitted on 27 Apr 2023
Termination of appointment of Mark Charles Inker as a director on 23 November 2022
Submitted on 24 Nov 2022
Confirmation statement made on 18 August 2022 with no updates
Submitted on 24 Aug 2022
Total exemption full accounts made up to 31 December 2021
Submitted on 10 Aug 2022
Confirmation statement made on 18 August 2021 with no updates
Submitted on 10 Sep 2021
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year